Initial pathology in aggressive pituitary tumours and carcinomas: 2b or not 2b?-that is the question

Eur J Endocrinol. 2023 Apr 5;188(4):C5-C8. doi: 10.1093/ejendo/lvad042.

¹ Faculty of medicine Lyon-Est, University Claude Bernard Lyon 1, Lyon 69372, France.
² Department of Endocrinology, Skåne University Hospital, Malmö, Lund University, Malmö 214 28, Sweden.
³ Department of Neurosurgery, IRCCS San Raffaele, Vita-Salute University, Milan 20132, Italy.
⁴ Department of Endocrinology, St. Vincent's Hospital, Sydney 2010, Australia.
⁵ ENDOC Center for Endocrine Tumors, Erik-Blumenfeld-Platz 27a, Hamburg 22587, Germany.
⁶ School of Medicine, University of Belgrade, Belgrade 11000, Serbia.
⁷ Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich 2333, Germany.
⁸ Department of Clinical Epidemiology, Leids Universitair Medisch Centrum Centrum voor Humane en Klinische Genetica, Leiden 2300 RC, Netherlands.
⁹ Federation d'Endocrinologie, Hospices civils de Lyon, Bron 69677, France.

No abstract available

MeSH terms